Home -> Law Blog Directory -> Intellectual Property Law Blogs -> IPKat
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: IPKatPatent pop quiz
By David

The IPKat (right: in inscrutable mode) would like to ask his readers a couple of little questions. Here is a headnote from a recent EPO Board of Appeal decision:
"The mere fact that subject-matter, which is excluded per se under Article 52(2) (c) EPC, is technically implemented cannot form the basis for inventive step. Inventive step can be based only on the particular manner of implementation of such subject-matter. To this end it is therefore necessary to ask how the per se excluded subject-matter is implemented."Now, the questions are:
1. What particular A52(2) exclusion is this decision about?
2. Given your answer to 1, would the same reasoning apply for the other exclusions?
Presumably someone will be able to name the decision itself, but the IPKat thought that it would be better to let his readers think about it first, before checking the web comments to find out.
Full post as published by IPKat on March 26, 2008 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment
Qualcomm Settles Patent Suit for $891 Million
The Princeton Review
$2.6 million settlement reached in patent infringement case.

Thursday Afternoon Fun: The NYU Prof Quiz
Try a word quiz on Triangle Grammar Guide
Take USA Today's U.S. Supreme Court quiz
How Smart of a Home Seller are You








